CVR number 29522162
Industry 86.9040 Other human health activities

KIROPRAKTISK KLINIK HOLTE ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  2.7% 1.0% 4.1% 7.0% 10.1%  
Credit score (0-100)  61 86 48 34 23  
Credit rating  BBB A BBB BBB BB  
Credit limit (kDKK)  0.0 108.9 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales  0 0 0 0 0  
Gross profit  913 1,416 2,416 -15.9 -14.1  
EBITDA  44.5 451 1,327 -465 -14.7  
EBIT  -211 207 1,313 -465 -14.7  
Pre-tax profit (PTP)  -215.6 204.5 1,311.0 -466.1 -14.7  
Net earnings  -170.8 155.0 996.6 -363.6 -11.5  
Pre-tax profit without non-rec. items  -216 204 1,311 -466 -14.7  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Tangible assets total  368 423 0.0 0.0 0.0  
Shareholders equity total  1,178 1,333 2,330 666 655  
Interest-bearing liabilities  116 73.7 28.1 28.1 28.1  
Balance sheet total (assets)  1,713 1,870 3,154 1,191 693  
Net Debt  -136 -471 -126 -218 20.0  
 
See the entire balance sheet

Volume 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  913 1,416 2,416 -15.9 -14.1  
Gross profit growth  -20.7% 55.1% 70.6% 0.0% 10.9%  
Employees  4 4 4 1 1  
Employee growth %  0.0% 0.0% 0.0% -75.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,713 1,870 3,154 1,191 693  
Balance sheet change%  -14.2% 9.1% 68.7% -62.2% -41.8%  
Added value  44.5 450.8 1,327.5 -451.0 -14.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -510 -389 -1,178 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 -1.0 -2.0  

Profitability 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -23.1% 14.6% 54.4% 2,933.2% 103.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -11.4% 11.5% 52.3% -21.4% -1.6%  
ROI %  -12.5% 12.9% 65.8% -30.5% -2.1%  
ROE %  -13.5% 12.3% 54.4% -24.3% -1.7%  

Solidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Equity ratio %  68.8% 71.3% 73.9% 55.9% 94.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -304.7% -104.5% -9.5% 46.9% -136.2%  
Gearing %  9.8% 5.5% 1.2% 4.2% 4.3%  
Net interest  0 0 0 0 0  
Financing costs %  4.1% 2.5% 4.4% 3.1% 0.1%  

Liquidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Quick Ratio  1.2 2.0 3.8 2.3 18.2  
Current Ratio  1.3 2.1 3.8 2.3 18.2  
Cash and cash equivalent  251.3 545.0 153.9 246.1 8.1  

Capital use efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  79.8 335.5 2,329.6 666.0 654.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales / employee  0 0 0 0 0  
Added value / employee  11 113 332 -451 -15  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  11 113 332 -465 -15  
EBIT / employee  -53 52 328 -465 -15  
Net earnings / employee  -43 39 249 -364 -11